fbpx Scott Berger - JPALS | JLABS

Scott Berger



Scott Berger Headshot

Scott Berger

Senior Director, Immunology TA

Janssen R&D US

Why I'm a JPAL

I enjoy working with companies to help shape and advance the next generation of transformational therapeutics for patients with high unmet medical need.


Scott Berger, Ph.D., is the Head of Innate Immunity, and a Senior Director within the Discovery Immunology group where he leads a team and portfolio focused on innate immune targets for auto-inflammatory diseases. Scott is also the discovery lead on the Gastrointestinal Disease Area Stronghold which is responsible for managing the end-to-end strategy for therapeutics focused on inflammatory diseases of the gut.

Prior to joining Johnson & Johnson in August 2019, Scott was a Senior Director at GlaxoSmithKline where he held various discovery and early development roles. In his last position at GSK, Scott led an innate immune group where he was responsible for setting strategy, prioritizing assets, and driving collaborations in the immunology space. Prior to this, Scott was an Early Development Leader and the single point of accountability for delivering compounds through Phase II in the clinic. In this role, he led large matrix teams which delivered multiple phase I studies, and proof of concept trials in psoriasis, rheumatoid arthritis and ulcerative colitis. In earlier roles, Scott was the Head of Biology for the Host Defensive Discovery Performance Unit which was focused on modulating the host immune response to combat infectious diseases, and the head of the in vivo pharmacology group within the Pattern Recognition Receptor Discovery Performance Unit. Prior to these roles, Scott was a project leader, taking multiple programs from target identification through to the delivery of compounds to the clinic.

Before transitioning to the pharmaceutical industry, Scott was a Postdoctoral Fellow in the immunology group at Harvard Medical School/Beth Israel Deaconess Medical Center where he identified novel pattern recognition receptors and worked to better understand the mechanistic underpinnings of inflammatory bowel disease.

Scott earned his undergraduate degree at SUNY Buffalo, where he discovered his excitement for biomedical and translational research. He subsequently earned his M.S. and Ph.D. in Biochemistry from the University of Michigan.


"If you dislike change, you're going to dislike irrelevance even more."

- General Eric Shinseki

Fun fact: